Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Due to lack of financial support
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| AstraZeneca | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Rating and registration in KMS database of all patients in anti-psychotic treatment with 8 selected items from PANSS, GAF, 21 selected items from UKU, 3 selected items from TSQM. and measurement of compliance. Frequency of use of rating scales per participating health care professional.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| GAF score >= 30 or have an improvement on >= 5 points at the GAF scale | All measures are rated every ½ year at least.GAF: At least 85 % of the rated patients must have a score >= 30 or have an improvement on >= 5 points at the GAF scale |
| Measure | Description | Time Frame |
|---|---|---|
| PANSS: Share af patients that have a score >= 3 on each an every of the following items P1, P2, P3, N1, N4, N6, G5, G9 | PANSS: At least 70% of the patients have a score <= 3 on each an every of the following items P1, P2, P3, N1, N4, N6, G5, G9 | |
| UKU: Share of patients that have a score <=1 on the selected 21 items from the UKU scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients that are treatet with antipsycotic medicine - by a specialist in psychiatry - the patients can stay at the hospital or receive outpatient treatment
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Soren Blikenberg | Research Centre for Psychiatry Vordingborg | Principal Investigator |
| Michael Maagensen | Children Psychiatry Holbaek | Principal Investigator |
| Karin Byrsting | Odense University Hospital Odense C Psychiatric Hospital Slagelse | Principal Investigator |
| Marianne Jacoby | Outpatient TreatmentCopenhagen K | Principal Investigator |
| Peter Christoffersen | Psychiatric Hospital Slagelse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Slagelse | Dianalund | Denmark | |||
| Research Site |
Not provided
| ID | Term |
|---|---|
| D017060 | Patient Satisfaction |
| ID | Term |
|---|---|
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| UKU: At least 75 % of the patients have a score on <=1 on the selected items UKU scale.At least 30 % of the patients are examined for metabolic syndrom. |
| Compliance: Share of patients have according to the specialists evaluation have taken their antipsychotic medicine according to prescription | Compliance: At least 75% of the patients have according to the specialists evaluation taken their antipsychotic medicine according to prescription |
| Patient satisfaction:Share of patients that scores in one of the to best categories i all selected 3 items in the TSQM scale. | Patient satisfaction:At least 65 % of the patients scores in one of the to best kategories in all the selected 3 items in the TSQM scale. |
| Bjerringbro |
| Denmark |
| Research Site | Brørup | Denmark |
| Research Site | Copenhagen | Denmark |
| Research Site | Esbjerg | Denmark |
| ResearcH Site | Holbæk | Denmark |
| Research Site | Hviding | Denmark |
| Research Site | Næstved | Denmark |
| Research Site | Thyholm | Denmark |
| Research Site | Varde | Denmark |